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Expression of green fluorescent 
protein defines a specific 
population of lamina II excitatory 
interneurons in the GRP::eGFP 
mouse
Andrew M. Bell1*, Maria Gutierrez‑Mecinas1, Anna Stevenson1, Adrian Casas‑Benito1, 
Hendrik Wildner2,3, Steven J. West4, Masahiko Watanabe5 & Andrew J. Todd1*
Dorsal horn excitatory interneurons that express gastrin‑releasing peptide (GRP) are part of the circuit 
for pruritogen‑evoked itch. They have been extensively studied in a transgenic line in which enhanced 
green fluorescent protein (eGFP) is expressed under control of the Grp gene. The GRP‑eGFP cells 
are separate from several other neurochemically‑defined excitatory interneuron populations, and 
correspond to a class previously defined as transient central cells. However, mRNA for GRP is widely 
distributed among excitatory interneurons in superficial dorsal horn. Here we show that although Grp 
mRNA is present in several transcriptomically‑defined populations, eGFP is restricted to a discrete 
subset of cells in the GRP::eGFP mouse, some of which express the neuromedin receptor 2 and 
likely belong to a cluster defined as Glut8. We show that these cells receive much of their excitatory 
synaptic input from MrgA3/MrgD‑expressing nociceptive/pruritoceptive afferents and C‑low threshold 
mechanoreceptors. Although the cells were not innervated by pruritoceptors expressing brain 
natriuretic peptide (BNP) most of them contained mRNA for NPR1, the receptor for BNP. In contrast, 
these cells received only ~ 10% of their excitatory input from other interneurons. These findings 
demonstrate that the GRP‑eGFP cells constitute a discrete population of excitatory interneurons with 
a characteristic pattern of synaptic input.
Neuronal circuits in the spinal dorsal horn process somatosensory information, which is then transmitted to the 
brain by projection cells. The vast majority of dorsal horn neurons are interneurons, and these can be assigned to 
two main classes: excitatory and inhibitory  cells1,2. Nociceptive and pruritoceptive primary afferents terminate in 
the superficial dorsal horn (SDH; laminae I-II), and ~ 75% of neurons in this region are excitatory  interneurons2. 
Recent studies have shown that these cells can be assigned to several largely non-overlapping populations, based 
on the expression of different  neuropeptides3–6, and these are thought to have distinct roles in pain and itch.
There is compelling evidence that gastrin-releasing peptide (GRP) and its receptor (GRPR) play a key role in 
itch. Intrathecal administration of GRP evokes scratching, while GRPR antagonists reduce scratching in response 
to  pruritogens7–11. In addition, mice lacking GRPR, or those in which GRPR-expressing dorsal horn neurons are 
ablated, show reduced responses in several itch  models7,8,12,13. Excitatory interneurons within the SDH provide a 
source of  GRP7,14–16, and several studies have investigated the role of these cells by using BAC transgenic mouse 
lines from the GENSAT  project17 in which either enhanced green fluorescent protein (eGFP)7,14,15,18–20 or Cre 
 recombinase18–21 is expressed under control of the Grp promoter (GRP::eGFP and GRP::Cre, respectively). We 
have reported that the eGFP-positive cells in the GRP::eGFP line are all excitatory, accounting for ~ 15% of the 
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excitatory interneurons in laminae I-II4,14, and that they are largely separate from populations defined by the 
expression of five other peptides: cholecystokinin (CCK), neurotensin, neurokinin B (NKB), neuropeptide FF 
(NPFF) and substance P (SP)3,4,22,23. Between them, these 6 populations account for ~ 75% of SDH excitatory 
interneurons, and each of the other populations maps onto clusters that were identified by Häring et al.5 in a 
recent transcriptomic study. Specifically, cells in laminae I-II that express these other peptides correspond to 
the Glut2 (CCK), Glut4 (neurotensin), Glut5-7 (NKB), Glut9 (NPFF) and Glut10-11 (SP) populations defined 
by Häring et al.
However, Häring et al.5 reported that Grp mRNA was widely distributed across several of the excitatory 
interneuron clusters that they identified (Glut5-12), suggesting that the Grp message may be expressed by many 
cells that lack eGFP in this transgenic line. In fact, studies of the GRP-eGFP  cells3,19,20 have shown that they 
form a relatively homogeneous population in terms of morphological, electrophysiological and pharmacological 
properties, and correspond to a class previously defined as transient central  cells24–26.
The initial aim of this study was therefore to compare the distribution of mRNAs for GRP and eGFP in the 
GRP::eGFP mouse, and determine whether the eGFP cells correspond to any of the transcriptomic populations 
identified by Häring et al.5. We also used anatomical methods, based on detection of the postsynaptic protein 
 Homer27,28, to quantify their excitatory synaptic input from different sources. Recent  studies18,19 have shown that 
GRP-eGFP cells are “secondary pruritoceptors”7, innervated by pruritoceptive afferents that express the mas-
related G protein-coupled receptor A3 (MrgA3)29, although it is not known what proportion of their excitatory 
synaptic input this accounts for. Huang et al9 identified another population of pruritoceptors, which express 
somatostatin (SST) and brain natriuretic peptide (BNP; also known as natriuretic polypeptide B, NPPB), and 
these could activate the GRP-eGFP cells either synaptically, or through the action of BNP on its receptor, natriu-
retic peptide receptor 1 (NPR1)7. It has been suggested that GRP-eGFP cells also respond to noxious  stimuli18, 
and these cells may therefore be innervated by nociceptive afferents. In addition, they overlap with the plexus of 
C low-threshold mechanoreceptors (C-LTMRs), which express vesicular glutamate transporter 3 (VGLUT3)3,30. 
We therefore quantified excitatory synaptic input from different sources to the GRP-eGFP cells, as well as testing 
them for the presence of NPR1.
Results
eGFP expression in the GRP::eGFP mouse is restricted to a molecularly distinct subset of excit‑
atory interneurons. To test whether Grp message is as widely distributed among SDH neurons as reported 
by Häring et al.5, we initially performed multiple-labelling fluorescent in situ hybridisation with RNAscope and 
determined the proportion of excitatory neurons in laminae I-II that had mRNA for GRP. We also investigated 
the relationship of GRP cells to those that express SST, because this peptide is present in the majority of excita-
tory interneurons in this  region4,5. To do this, we analysed sections from three wild-type C57BL/6 mice that 
had been reacted with probes for Grp, Slc17a6 (the gene coding for vesicular glutamate transporter 2, VGLUT2, 
which is thought to be expressed by all excitatory interneurons in this  region31) and SST. We identified between 
360 and 412 (mean 386) excitatory (Slc17a6 +) cells in laminae I-II from each animal and found that 37% (range 
35–38%) of these were labelled for Grp mRNA and 66% (63–69%) for SST mRNA. The great majority (83%, range 
80–85%) of the Grp + cells were also positive for SST, and these accounted for 47% (43–50%) of all SST + cells 
(Fig. 1). Although Fatima et al.32 recently estimated that only 16% of GRP cells expressed SST and that 5% of SST 
cells were GRP +, their identification of SST cells was based on a genetic strategy rather than direct observation 
of the mRNA, and this presumably accounts for the difference between these values. The finding that 66% of 
VGLUT2 + neurons contain mRNA for SST is consistent with our previous estimate that 59% of excitatory SDH 
neurons are SST-immunoreactive4. Taken together, these results are in agreement with those of Häring et al.5, 
and show that GRP and SST overlap extensively in laminae I-II, and are both widely expressed among the excita-
tory interneurons in this region.
We next revealed the mRNAs for both GRP and eGFP in sections from three GRP::eGFP mice and found that 
while all eGFP-positive cells were also labelled with the Grp probe, they only accounted for 23.3% (20.1–26.2%) 
of the Grp + cells in laminae I-II (Table 1, Fig. 2). Albisetti et al.20 recently examined the GRP::Cre line and 
showed that only 25% of cells with Grp mRNA expressed Cre. Sun et al.18 had previously crossed the GRP::eGFP 
and GRP::Cre lines and shown that 90% of the Cre + cells had eGFP, while 64% of eGFP cells were Cre-positive, 
indicating that the two lines capture a largely overlapping population. Collectively, these findings indicate that 
while the cells that are labelled in these two BAC transgenic lines are all GRP-expressing, they only account for 
a minority of the GRP cells.
Since GRP is highly expressed among the Glut5-12 clusters of Häring et al.5, we then compared the distribu-
tion of both Grp and eGFP mRNAs with those of other markers that can be used to reveal these populations. 
This analysis was again performed in laminae I-II in 3 GRP::eGFP mice and results are shown in Table 1 and 
Fig. 2. The tachykinin peptides SP and NKB are encoded by Tac1 and Tac2 and are expressed by the Glut5-7 and 
Glut10-11 clusters, respectively, while the neuromedin receptor 2 (Nmur2) is expressed in the Glut8  cluster5. In 
the case of Tac2 mRNA we found, as reported by Häring et al.5, that there were two populations: those with high 
and low levels (corresponding to Glut5-6 and Glut7, respectively), and we therefore analysed these separately. 
For both of the tachykinin peptides, we found a moderate degree of overlap with Grp mRNA, such that ~ 10% 
and 25% of cells with Grp mRNA also contained Tac1 or Tac2 mRNA (respectively), while around 15% of Tac1 
and 50% of Tac2 cells had Grp mRNA. However, there was minimal overlap of tachykinin and eGFP expression, 
since only < 1% of Tac1 mRNA cells and < 2% of Tac2 mRNA cells were positive for eGFP. In contrast, Nmur2 
mRNA showed a moderate degree of overlap with both Grp and eGFP mRNA. Specifically, 30% of Grp + cells and 
26% of eGFP + cells contained Nmur2 mRNA, and these corresponded to 69% and 14% of the Nmur2 population, 
respectively. We have previously shown that Npff mRNA overlaps with Grp mRNA, but that GRP-eGFP cells are 
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not NPFF-immunoreactive22, indicating that although Grp message is present in cells in the Glut9 cluster, GRP-
eGFP cells are excluded from this cluster (Fig. 2m). Taken together, these results show that eGFP expression is 
restricted to a distinct subset of GRP cells.
Pruritoceptive input to GRP‑eGFP cells. Two major classes of primary afferent have been identified as 
potential pruritoceptors: those defined by expression of  MrgA329 and SST/BNP9, and these correspond, respec-
tively, to the NP2 and NP3 classes defined by Usoskin et al.33. We therefore quantified synaptic input to GRP-
eGFP cells from these two populations.
Input from MrgA3 afferents was analysed in tissue from 2 GRP::eGFP;MrgA3::Cre;Ai14 mice, in which these 
afferents express  tdTomato29, and sections were stained to reveal tdTomato, eGFP and Homer. As noted by Albi-
setti et al.20, we found a high degree of overlap between the plexus of MrgA3 afferents and the dendritic trees of 
the GRP-eGFP neurons in lamina II, and we observed numerous contacts between these profiles (Fig. 3). We 
found that tdTomato-positive boutons were in contact with ~ 25% of the Homer puncta on the dendritic trees 
of the GRP-eGFP cells (Figs. 3, 4), and these accounted for 29.4% (22.9–36%) of the Homer puncta that were 
contacted by MrgA3 boutons. However, only 9.1% (8.4–9.8%) of all Homer puncta within the band of GRP-eGFP 
dendrites were associated with an eGFP-labelled profile. This corresponds to a threefold enrichment on GRP-
eGFP cell dendrites, and shows that MrgA3 boutons preferentially target the GRP-eGFP cells.
Figure 1.  Co-localisation of mRNAs for VGLUT2, somatostatin and GRP revealed by fluorescent in situ 
hybridisation. (a–c) Part of lamina II in a section reacted with probes for Grp (green), Slc17a6 (the gene that 
encodes VGLUT2, red) and SST (blue). In each case nuclei, which were stained with NucBlue, are shown in 
grey. (d) A merged image of the same field. This region contains several cells that are positive for each probe. 
Asterisks show two cells that are positive for all 3 probes, and the arrow points to a cell that has mRNAs 
for VGLUT2 and SST, but not for GRP. (e) Venn diagram showing the proportions of VGLUT2 cells that 
are positive for SST and/or Grp mRNAs. Images in (a–d) are projections of confocal optical sections (1 μm 
z-separation) taken through the full thickness of the section. Scale bar for (a–d): 20 μm.
Table 1.  Quantitative in situ hybridisation data. Data are presented from 3 animals in each case and are shown 
as mean (range). a The corresponding percentage given in the “Results” section was obtained by pooling data 
from each individual animal, giving a mean of 23.3% with a range of 20.1–26.2%.
Other mRNA No. Grp + cells
No. 
eGFP + cells
% Grp + with 
eGFPa
No. Tac1 + , 
Tac2 + or 
Nmur2 + (Other) 
cells
No. Other 
cells with Grp
% Other cells 
with Grp
No. Other 
cells with 
eGFP
% Other cells 
with eGFP
% Grp + with 
other marker
% 
eGFP + with 
other 
marker
Tac1 253.6 (185–305) 57.6 (49–69)
23.3% 
(18.0–26.5) 170.3 (136–208) 28 (15–39)
15.9 
(11.0–18.8) 1.3 (0–2) 0.7 (0–1.2)
10.7 
(8.1–12.8) 2.2 (0–3.6)
Tac2 High
296.3 
(237–356) 69.6 (64–80)
23.8 
(22.0–27.0)
73.3 (46–99) 40 (25–58) 54.1 (49.3–58.6) 1.0 (0–2) 1.2 (0–2.7)
13.1 
(10.5–16.3) 0.3 (0–0.7)
Tac2 Low 77.3 (58–88) 36 (27–50) 47.2 (31.4–56.8) 1.3 (1–2) 1.7 (1.1–2.3)
12.1 
(9.2–14.0) 0.5 (0.3–0.7)
Nmur2 201.6 (165–237) 46.3 (41–55)
23.1% 
(21.2–24.8) 87.3 (78–105) 60.3 (54–72)
69.1 
(68.8–69.6) 12 (8–15)
13.7 
(10.3–16.5)
30.1 
(26.6–33.3)
25.9 
(18.6–31.7)
4Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:13176  | https://doi.org/10.1038/s41598-020-69711-7
www.nature.com/scientificreports/
To look for evidence of input from SST-expressing primary afferents, we needed to distinguish these from 
Figure 2.  The relationship between mRNAs for GRP, eGFP and other neurochemical markers in the 
GRP::eGFP mouse. (a–d), (e–h) and (i–l) show parts of lamina II in sections reacted with probes directed 
against the mRNA for GRP (a, e, i), eGFP (b, f, j) and either Tac1 (c), Tac2 (g) or Nmur2 (k). Merged images are 
also shown (d, h, l). In each case the probe for GRP is shown in red, that for eGFP in green and that for the other 
marker in blue. In all of these images counterstaining for NucBlue is shown in grey. (a–d) This field shows 2 cells 
that are positive for both Grp and eGFP, but negative for Tac1 (asterisks), as well as several Tac1-positive cells 
that lack mRNA for GRP and eGFP (two shown with arrows). (e–h) The cell marked with an asterisk is positive 
for both Grp and eGFP, but negative for Tac2, while that shown with the arrowhead is strongly positive for Tac2 
(Tac2high) but negative for Grp and eGFP. Two other cells (arrows) show low levels of Tac2 (Tac2low) and are 
positive for Grp but negative for eGFP. (i–l) This field shows two Grp-positive/eGFP-positive cells one of which 
(arrow) is positive for Nmur2 (arrow) and one of which lacks Nmur2 mRNA (asterisk). (m) Venn diagrams 
illustrating the extent of overlap between these different populations. The data for Npff is obtained from a 
previous  study22 in which we reported that there was some overlap between mRNAs for GRP and NPFF, but that 
cells immunoreactive for pro-NPFF were never eGFP-positive in the GRP::eGFP mouse. This is shown here to 
allow comparison with the results for other neurochemical markers. Images in (a–l) are projections of confocal 
optical sections (1 μm z-separation) taken through the full thickness of the section. Scale bar (for a–l) = 20 μm.
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boutons belonging to SST-expressing  interneurons4. To do this, we used an antibody against prostatic acid 
phosphatase (PAP), which is expressed by the majority of non-peptidergic  afferents33,34. We first validated this 
approach by reacting sections from mice in which eGFP is expressed under control of the promoter for Advillin 
(Avil::eGFP), and is therefore restricted to primary  afferents35. This analysis showed that virtually all (99%) of 
the SST primary afferents, defined by co-localisation of SST and eGFP, were PAP-immunoreactive, and that these 
were restricted to the middle and outer parts of lamina II (Fig. 5a–e). We therefore immunoreacted sections 
from GRP::eGFP mice to reveal SST, PAP, eGFP and Homer. We found that SST +/PAP + boutons seldom con-
tacted eGFP dendrites, accounting for only 4.1% (2.4–4.7%) of the Homer puncta associated with these boutons 
(Fig. 5f). Since these apparently make up a very small part of the excitatory synaptic input to the GRP-eGFP cells, 
we did not quantify the input from SST afferents to individual GRP-eGFP cells.
To test whether GRP-eGFP cells possessed the receptor for BNP, and could therefore respond to peptidergic 
(rather than synaptic) signalling from the SST/BNP afferents, we performed fluorescent in situ hybridisation 
with probe directed against NPR1 mRNA. Labelling was present over certain cells in the SDH (Fig. 5g–j), and 
we found that 77% of eGFP cells were NPR1-positive, whereas the proportion was only 32% for those GRP cells 
that lacked eGFP mRNA. These proportions were significantly different (Mantel–Haenszel common odds ratio 
estimate for NPR1 expression in eGFP + cells vs eGFP− cells = 8.2; 95% CI 5.9–11.2, p < 0.0001), showing that 
Figure 3.  Synaptic input to GRP-eGFP cells from two classes of non-peptidergic C afferent. (a–f) Part of lamina 
II shown in a sagittal section from a GRP::eGFP;MrgA3::Cre;Ai14 mouse scanned to reveal tdTomato (red), 
which labels MrgA3 afferents, eGFP (green) and Homer (blue). (a) and (b) show a projected confocal image 
taken from 61 optical sections at 0.2 μm z-separation. Numerous contacts between tdTomato-positive boutons 
and the dendrites of the GRP-eGFP cells can be seen. The box in (b) indicates the region illustrated at higher 
magnification in (c–f). (c–f) a single optical section shows several appositions between tdTomato-labelled 
boutons and eGFP-labelled dendrites at which a Homer punctum is present (four indicated with arrowheads). 
(g–l) Part of lamina II in a sagittal section from a GRP::eGFP;MrgDCreERT2;Ai9 mouse scanned for tdTomato 
(red), which labels MrgD afferents, eGFP (green) and Homer (blue). (g) and (h) show a projected confocal 
image from 21 optical sections at 0.2 μm z-spacing. Again, contacts between tdTomato-positive boutons 
and dendrites of GRP-eGFP cells are visible. (i–l) A higher magnification view taken from a projection of 5 
z-sections corresponding to the region shown in the box in (h), showing 3 contacts at which a Homer punctum 
is present (arrowheads). Scale bars: (a,b) and (g,h) = 20 μm, (c–f) and (i–l) = 5 μm.
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GRP-eGFP cells are more likely to express NPR1 than other GRP cells (Table S1). However, NPR1 expression was 
not exclusive to GRP cells, as Grp mRNA was only detected in 57% of NPR1 + cells (Table S1).
Other excitatory synaptic inputs to GRP‑eGFP cells. Primary afferents that express MrgD cor-
respond to the NP1 class of Usoskin et  al.33, and their central projections overlap extensively with the den-
dritic trees of the GRP-eGFP cells. We therefore analysed input from MrgD afferents to GRP-eGFP cells in 
2 GRP::eGFP;MrgDCreERT2;Ai9 mice (in which tdTomato is expressed by MrgD  afferents36), using the same 
approach as that described above. We found that the dendrites of the GRP-eGFP cells were co-extensive with 
the plexus of MrgD afferents (Fig.  3g,h), and numerous Homer-associated contacts were seen. These repre-
sented ~ 14% of the Homer puncta on the dendritic trees of the GRP-eGFP cells (Figs. 3, 4), while GRP-eGFP 
dendrites accounted for 14% (12.9–15.1%) of the Homer puncta that were in contact with MrgD boutons.
Sun et al.18 used monosynaptic rabies tracing to identify inputs to GRP-Cre cells in the GRP::Cre line, and 
reported that these cells were innervated by CGRP-expressing primary afferents. We therefore analysed synaptic 
input to GRP-eGFP cells from CGRP-immunoreactive boutons. There was little spatial overlap between the GRP-
eGFP cells and the CGRP plexus (Fig. 6a–c), and CGRP boutons were present at only 1.6% of the Homer puncta 
on the GRP-eGFP cells (Fig. 4). Within the GRP-eGFP plexus, GFP-labelled profiles were associated with 4.5% 
(3.5–5%) of the Homer puncta adjacent to CGRP boutons. This suggests that CGRP-immunoreactive boutons 
provide a very limited synaptic input to GRP-eGFP cells.
In a previous study, we noted that GRP-eGFP cells were largely restricted to regions of the dorsal horn that 
were innervated by hairy  skin3. This was demonstrated by revealing C-LTMRs (which are also restricted to hairy 
skin) with an antibody against  VGLUT330. During the course of that study we found frequent contacts between 
VGLUT3-immunoreactive boutons and GRP-eGFP cells, although only those GRP-eGFP cells in the ventral 
half of the eGFP band overlapped the VGLUT3 plexus (see Fig. 1 of Dickie et al.30). We therefore quantified the 
synaptic input from VGLUT3 boutons to eGFP cells that were either within this plexus or dorsal to it. We found 
that for GRP-eGFP cells within the VGLUT3 plexus, 42% of their Homer puncta were associated with VGLUT3 
boutons (Figs. 4, 7). Unsurprisingly, the input was far less dense for eGFP cells located dorsal to the VGLUT3 
plexus, for which only 8% of Homer puncta were adjacent to a VGLUT3 bouton (Fig. 4). Conversely, GRP-eGFP 
dendrites were identified at between 8.8 and 23.2% (mean 14.6%) of the Homer puncta that were adjacent to 
VGLUT3 boutons. As this was apparently the first indication that C-LTMRs provide synaptic input to GRP-eGFP 
cells, we used a combined confocal/electron microscopy  approach37 to confirm that the appositions corresponded 
to synapses. We identified 8 Homer-associated VGLUT3 contacts onto a single GRP-eGFP cell from each of two 
GRP::eGFP mice with the electron microscope. We found that, as reported  recently38, the VGLUT3 boutons cor-
responded to central axons of synaptic glomeruli, which were presynaptic to several dendritic profiles and were 
postsynaptic to profiles that resembled peripheral axons (Fig. 7k–m). We were able to confirm the presence of 
asymmetrical synapses onto the GRP-eGFP dendrites at 15 of the 16 contacts identified.
Finally, we investigated synaptic input to the GRP-eGFP cells from VGLUT2-immunoreactive boutons. 
Although many unmyelinated primary afferents express  VGLUT239, the level of immunoreactivity in their central 
terminals is typically very low, and the majority of boutons with strong VGLUT2 immunoreactivity are thought 
Figure 4.  The contribution of different types of glutamateric input to GRP-eGFP cells. Scatter plot showing the 
percentage of Homer puncta on these cells that were in contact with axons defined by the expression of different 
markers. For VGLUT3, we tested GRP-eGFP cells that had dendritic trees both within and outside the VGLUT3 
plexus, and the latter are shown separately (VGLUT3*). The numbers of cells tested for each axonal population 
are shown in table S4. Each symbol represents an individual cell, and the mean and standard deviation are 
shown.
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to originate from local excitatory  interneurons14,31. We examined sections from 5 GRP::eGFP mice that had been 
reacted to reveal VGLUT2, Homer and eGFP and analysed the input to 16 GRP-eGFP cells (2–4 cells per mouse). 
Although all of the cells received contacts from boutons with strong VGLUT2 immunoreactivity at some of their 
Homer puncta, these only accounted for ~ 10% of the puncta on these cells (Figs. 4, 6). This suggests that excita-
tory interneurons provide only a relatively small part of the excitatory synaptic input to the GRP-eGFP cells.
Discussion
Our main findings are: (1) that although Grp mRNA is widely expressed among different populations of excita-
tory interneurons, eGFP expression in the GRP::eGFP mouse is restricted to a specific subset, with some of these 
cells co-expressing Nmur2; (2) that GRP-eGFP cells receive many excitatory synapses from primary afferents 
that express MrgA3, MrgD or (for those cells in lamina IIi) VGLUT3, but few from those that express CGRP or 
SST; (3) that most of these cells express the receptor for BNP; and (4) that they receive few synapses from bou-
tons with strong VGLUT2-immunoreactivity, which are likely to originate from local excitatory interneurons.
Recent  neurochemical2–4,22 and  transcriptomic5,6,40 studies have revealed several distinct populations among 
the excitatory interneurons in the SDH. For example, we have identified largely non-overlapping classes that 
express CCK, neurotensin, NKB, NPFF and SP, and found that these were different from the GRP-eGFP  cells22. 
However, this finding was apparently at odds with that of Häring et al., who reported that Grp mRNA was widely 
expressed, including by cells in clusters defined by the expression of three of these peptides (NKB, NPFF and 
SP). The present findings help to resolve this discrepancy, by showing that the Grp mRNA+ cells that co-express 
these neuropeptides are those that lack eGFP in the GRP::eGFP line, and that the GRP-eGFP cells therefore 
Figure 5.  Somatostatin afferents as a potential source of input to GRP-eGFP cells. (a–d) Somatostatin-
expressing primary afferents were initially revealed in tissue from the Avil::eGFP mouse, by immunostaining 
for somatostatin (SST, red), eGFP (green) and prostatic acid phosphatase (PAP, blue). These images are from 
a single confocal optical section through lamina IIo and show two eGFP + boutons, both of which are also 
PAP-immunoreactive. One of these (arrow) is SST-positive, indicating that it originates from a SST-expressing 
primary afferent, while the other (arrowhead) lacks SST. (e) The distribution of SST-afferents revealed by 
coexpression of PAP and SST seen in a single 60 μm thick section. Note that these are largely restricted to lamina 
IIo. (f) Part of a sagittal section through lamina II from a GRP::eGFP mouse, immunostained to reveal PAP 
(blue), eGFP (green) and SST (red). The image is projected from 13 optical sections at 0.2 μm z-separation. Two 
large SST afferent boutons, identified by the presence of SST and PAP are close to the dendrite of a GRP-eGFP 
cell, but are not in direct contact. (g–j) Fluorescent in situ hybridisation on a section from a GRP::eGFP mouse 
shows two cells (arrows) that are labelled with probes against both Grp and eGFP mRNAs, and both of which 
are also NPR1-positive. Images in (g–j) are projections of confocal images (1 μm z-separation) taken through 
the full thickness of the section. Scale bars: (a–d) = 5 μm, (f) = 5 μm, (g–j) = 20 μm.
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represent a highly specific population that shows virtually no overlap with any of these neuropeptide popula-
tions. As noted above, GRP itself is expressed among several transcriptomic clusters (Glut5-12)5, but for the 
GRP-eGFP cells, we can rule out those that express NKB (Glut5-7), NPFF (Glut9) and SP (Glut10-11). This leaves 
two remaining clusters: Glut8 and Glut12. Glut12 is characterised by expression of  GRPR5, and we have found 
no overlap between GRP::eGFP cells and those that are Cre-positive in a  GRPRCreERT2 mouse  line41 (MG-M and 
AJT, unpublished data), consistent with the report by Albisetti et al.20 that there is no overlap between mRNAs 
for GRP and GRPR. Our finding that ~ 25% of the eGFP + cells contained Nmur2 mRNA suggests that at least 
some of them belong to the Glut8  cluster5. The proportion belonging to Glut8 may be considerably higher than 
25%, because not all cells in this cluster apparently express  Nmur25. Interestingly, we had previously reported that 
GRP-eGFP cells were largely absent from the medial part of the dorsal horn (glabrous skin territory) in the L4-5 
 segments3. Although Häring et al.5 do not indicate which lumbar segments were used to analyse the distribu-
tion of the different clusters in their Fig. 5, the Glut8 cells are far more numerous in the lateral half of the dorsal 
horn, suggesting that these cells may also be at least partially excluded from regions innervated by glabrous skin.
Unlike Häring et al., Sathyamurthy et al.6 identify a population of excitatory interneurons based on Grp 
mRNA expression, which they define as DE1. However, these cells do not appear to express Nmur2, and given 
the widespread distribution of Grp mRNA that we observed in other well-defined neuropeptide populations, it 
is difficult to interpret this finding.
Since our results show that eGFP is expressed in a distinct subset of GRP neurons, this raises the question as 
to why this should occur. There are various reasons why BAC transgenic mice may show unexpectedly restricted 
expression patterns. The region of chromatin where the BAC has integrated may be silenced in certain neurons. 
Alternatively, fragmentation of the BAC may have occurred, resulting in loss of some regulatory elements, 
and there may be certain regulatory elements at a large distance from the transcription start site that were not 
included in the BAC. In either of these cases, expression of the transgene may be restricted to a specific subset 
of the expected population.
Our results provide novel information concerning the excitatory synaptic input to the GRP-eGFP cells. 
Albisetti et al.20 and Pagani et al.19 had already demonstrated that MrgA3-expressing pruritoceptive afferents 
innervate these cells. Here we show that they provide around a quarter of their excitatory synaptic input, and that 
this represents a selective targeting of the GPR-eGFP population by these afferents. In contrast, another major 
population of pruritoceptors, those that express SST and BNP provide little synaptic input to the GRP-eGFP 
cells, but are presumably able to influence them via the action of BNP on  NPR17, since mRNA for the receptor 
was present in ~ 80% of these cells. Some cells in the Glut8 population express the mRNA for  NPR35, and BNP 
might therefore also interact with this receptor on the GRP-eGFP cells. The post-synaptic targets of the SST/
BNP afferents are as yet unknown, but the SST that they release (together with that from SST-expressing excita-
tory interneurons) is thought to contribute to itch via a disinhibitory mechanism involving  Sst2a receptors on 
dynorphin-expressing inhibitory  interneurons9.
Figure 6.  Limited input to GRP-eGFP cells from peptidergic nociceptors and boutons with strong VGLUT2-
immunoreactivity. (a–c) Part of laminae I and II in a sagittal section from a GRP::eGFP mouse to show the 
relationship between the plexus of CGRP-immunoreactive axons (red), which are mainly located in lamina I and 
IIo, and the band of GRP-eGFP cells and dendrites (green). Although there is some overlap, the great majority of 
CGRP boutons are located dorsal to the GRP-eGFP band. The images were obtained from 51 optical sections at 
0.2 μm z-spacing. (d,e) Part of lamina II in a section from a GRP::eGFP mouse stained to show VGLUT2 (red), 
Homer (blue) and eGFP (green) in a projection of 11 optical sections at 0.2 μm z-separation. Although there are 
many VGLUT2-immunoreactive boutons in this field, they are seldom associated with Homer puncta on the 
GRP-eGFP cell. Scale bars: (a–c) = 50 μm, (d–f) = 20 μm.
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We also provide evidence that the GRP-eGFP cells receive ~ 15% of their excitatory input from MrgD-express-
ing afferents. Although these are thought to function as mechanical  nociceptors42, MrgD is the receptor for the 
pruritogen β-alanine32,43,44. Interestingly, it has recently been reported the MrgA3 afferents, which have a well-
established role in chloroquine-evoked  itch29, can also function as nociceptors engaging central opioid-responsive 
 circuits45. Together, these findings are consistent with the involvement of the GRP-eGFP cells in both pruritocep-
tive and nociceptive  transmission18. We have previously reported that the great majority of the GRP-eGFP cells 
Figure 7.  Synaptic input to GRP-eGFP cells from C-low threshold mechanoreceptors (C-LTMRs). (a) A 
sagittal section from a GRP::eGFP mouse that had been immunostained to reveal VGLUT3 (red) and eGFP 
(green) (24 optical sections at 0.2 μm z-spacing). Part of the cell body and dendritic tree of a GRP-eGFP can 
be seen lying within the plexus of VGLUT3-immunoreactive profiles, which correspond to C-LTMRs. (b–e) A 
detail from the same field in a projection of 6 optical sections (corresponding to the box in a), with staining for 
Homer (blue) also included. Two contacts between VGLUT3 boutons and GRP-eGFP dendritic spines at which 
Homer is present are indicated with arrowheads. (f–m) Combined confocal and electron microscopy to reveal 
synapses. (f) Part of the soma and dendrites of a GRP-eGFP cell in a projection of 36 optical sections at 0.2 μm 
z-spacing. (g–j) A higher magnification view (single optical section) of the boxed region in (f), scanned to 
reveal eGFP (green), VGLUT3 (red) and Homer (blue). The arrowhead points to a Homer punctum associated 
with an eGFP-labelled dendritic spine that is in contact with a large VGLUT3-positive bouton. (k–m) Electron 
microscopic images that correspond to part of the field shown in (g–j). The VGLUT3-positive bouton is shown 
to correspond to the central bouton of a synaptic glomerulus (g), and this forms a synapse on the eGFP-labelled 
dendritic spine (S), indicated with an arrow in (m). The VGLUT3 bouton is in synaptic contact with several 
other profiles, including a peripheral bouton (P) shown in (l) that is presynaptic to it at an axoaxonic synapse 
(arrow). Note that the images shown in (l) and (m) were taken after tilting the specimen in the electron beam to 
show synaptic specialisations more clearly. Scale bars: (a) = 20 μm, (b–e) = 5 μm, (f) = 10 μm, (k) = 1 μm.
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show outward currents during the application of DAMGO, indicating that they possess μ-opioid  receptors3, and 
this provides further support for the suggestion that GRP-eGFP cells engage nociceptive circuits. The finding 
that some of these cells express the mRNA for Nmur2 is also of interest, since mice lacking this receptor show 
reduced pain  behaviours46,47. However, despite the synaptic input that the GRP-eGFP cells receive from noci-
ceptive and pruritoceptive afferents, we have found that these cells seldom show phosphorylated extracellular 
signal-regulated kinases in response to either noxious or pruritic  stimuli3. It will therefore be important in future 
studies to assess their responses to stimuli applied to their receptive fields.
Our findings indicate that GRP-eGFP cells in lamina IIi receive numerous synapses from VGLUT3-immu-
noreactive profiles, which originate from C-LTMRs. It has been suggested that these afferents may contribute 
to mechanically-evoked itch in  humans48, although there is apparently little evidence for such a role in rodents. 
Alternatively, the circuit involving C-LTMRs and GRP-eGFP cells may contribute to the phenomenon of "affec-
tive touch", which is thought to be the main function for these  afferents49.
Sun et al.18 reported that 64% of the dorsal root ganglion neurons trans-synaptically labelled from the 
GRP::Cre line were CGRP-immunoreactive, suggesting a strong input to these cells from peptidergic nociceptors. 
However, peptidergic nociceptors have high levels of TRPV1 and we had previously found that the GRP-eGFP 
cells rarely showed increased miniature EPSC frequency during application of the TRPV1 agonist  capsaicin3, 
suggesting that they were seldom innervated by this class of afferent. Consistent with this, we found that CGRP-
immunoreactive boutons provided a very small proportion of the input to the GRP-eGFP cells. The most likely 
explanation for this discrepancy is that some cells with CGRP in their cell bodies do not have detectable levels 
of the peptide in their central terminals, and these are known to include the MrgA3  afferents29.
One unexpected finding was the low proportion (~ 10%) of Homer puncta on the GRP-eGFP cells that were 
associated with boutons showing strong VGLUT2-immunoreactivity, most of which are thought to originate 
from local excitatory  interneurons14,31. Together with the relatively high proportions of Homer puncta that were 
associated with defined primary afferent populations, this suggests that these cells receive the great majority of 
their excitatory synaptic input from primary afferents, rather than from other excitatory interneurons. We have 
recently examined the input to a different interneuron population, cells that express SP, and found that for these 
cells boutons with strong VGLUT2 immunoreactivity contact nearly half of the Homer  puncta50, suggesting that 
the pattern of input to different types of interneurons varies considerably. Interestingly, we found that in slice 
preparations GRP-eGFP cells had exceptionally low spontaneous EPSC frequencies (mean 0.02 Hz, compared 
to ~ 3 Hz for SP cells)3. Primary afferents were transected during the slice preparation, and since it is known 
that axotomy can reduce the capacity for vesicle release from  boutons51, this may have contributed to the low 
spontaneous EPSC frequency. Alternatively, these afferents may have a naturally low release probability.
Although it is not possible to determine what proportion of excitatory synaptic input is accounted for by the 
different sources examined here, it is unlikely that we have been able to identify all of the input to the GRP-eGFP 
cells. The remainder may include contributions from other classes of primary afferent (e.g. myelinated  LTMRs21, 
thermoreceptors or those that express  MrgB452) as well as from descending sources such as the corticospinal 
 tract27.
Overall, our findings suggest that although the GRP-eGFP cells are a source of GRP in the dorsal horn, the 
peptide can also be released from other excitatory interneurons that are not captured in this line. Our under-
standing of the distribution of GRP within the dorsal horn has been limited by the cross-reaction of at least 
some GRP antibodies with other peptides, in particular  SP14,53, which results in false-positive labelling of many 
peptidergic nociceptors in immunohistochemical studies (although see  reference54). However, we reported that 
GRP immunoreactivity could also be detected in ~ 30% of boutons with strong VGLUT2 in laminae I-IIo, most 
of which are likely to have originated from excitatory  interneurons14. We also showed that in the GRP::eGFP 
mouse, around 75% of eGFP-labelled boutons had detectable GRP-immunoreactivity but that these accounted 
for only 40% of the boutons that were both VGLUT2- and GRP-immunoreactive. This would be consistent with 
the presence of GRP in some GFP-negative excitatory interneurons, although some of this staining may have 
resulted from cross-reaction with SP in boutons of SP-expressing interneurons.
Anatomical and electrophysiological evidence has indicated that the GRP-eGFP cells target another popu-
lation of excitatory interneurons, which are defined by the expression of  GRPR19. Activation of the GRPR-
expressing cells depended on both a glutamatergic synaptic mechanism, and simultaneous action of GRP on the 
GRPR, and this connection is thought to be part of the spinal cord circuit for itch, conveying information from 
pruritoceptors via these two classes of interneuron (secondary and tertiary pruritoceptors) to anterolateral tract 
(ALT) projection neurons in lamina  I7,9. However, a recent  study55 identified GRPR neurons as vertical cells, and 
this is consistent with our observations from a  GRPRCreERT2 mouse  line41 (MG-M, EP, AMB, AJT, unpublished 
data). Two independent groups have shown that GRP-eGFP cells correspond to a population identified by Grudt 
and  Perl24 as transient central  cells3,19,20. Interestingly, paired recording studies in spinal cord slices had previously 
shown that transient central cells were presynaptic to vertical  cells26, but this was thought to be part of a circuit 
that could convey low-threshold mechanoreceptive information to lamina I ALT cells, which, when disinhibited 
led to tactile  allodynia25. This raises the question of whether the transient central to vertical cell circuit contributes 
to tactile allodynia, itch or both. In addition, the present results suggest that this connection may be involved in 
transmitting information from C-LTMRs to lamina I ALT cells, consistent with the finding that affective touch 
is lost following anterolateral cordotomy, in which the ALT is  disrupted49.
Methods
Animals. All experiments were approved by the Ethical Review Process Applications Panel of the University 
of Glasgow, and were performed in accordance with the European Community directive 86/609/EC and the UK 
Animals (Scientific Procedures) Act 1986.
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Fluorescent in situ hybridisation. Multiple-labelling fluorescent in  situ hybridisation was carried out 
with RNAscope probes and RNAscope fluorescent multiplex reagent kit 320,850 (ACD BioTechne; Newark, CA 
94560). Fresh frozen lumbar spinal cords from 3 wild-type C57BL/6 mice (either sex, 18–20 g) and 3 GRP::eGFP 
mice (GENSAT) (either sex, 20–24 g) were embedded in OCT medium and cut into 12 μm thick transverse sec-
tions with a cryostat (Leica CM1950; Leica, Milton Keynes, UK). Sections were mounted non-sequentially (such 
that sections on the same slide were at least 4 apart) onto SuperFrost Plus slides (48311-703; VWR; Lutterworth, 
UK) and air dried. Reactions were performed according to the manufacturer’s recommended protocol. The 
probes used in this study, and the proteins/peptides that they correspond to, are listed in Table S2. Five different 
probe combinations were used. The first consisted of Grp (channel 1), Slc17a6 (channel 2) and Sst (channel 3). 
For the other four, the probes for channel 1 and channel 2 were Grp and eGFP, respectively, while the  3rd channel 
probe was Tac1, Tac2, Nmur2 or NPR1. Positive and negative control probes were also tested on other sections 
as described  previously23. Sections were mounted with Prolong‐Glass anti‐fade medium with NucBlue (Hoechst 
33342) (ThermoFisher Scientific, Paisley, UK) and scanned with a Zeiss LSM 710 confocal microscope through 
the 40 × oil‐immersion lens (numerical aperture 1.3) with the confocal aperture set to 1 Airy unit. Sections were 
selected prior to viewing in situ hybridization fluorescence, to avoid bias and for each section the full thickness 
was acquired with a 1 μm z-step, using tile scanning to include the whole of laminae I and II.
Analysis of the relationship between Sst, Grp and Slc17a6 was conducted on a single representative optical 
section from the centre of the image stack using the cell detection and subcellular objects features of Qupath 
software (Qupath, University of Edinburgh, Edinburgh, UK). Recognition and segmentation of individual nuclei 
was performed based on NucBlue staining and an additional 2 μm perimeter was added to each nucleus to allow 
detection of perinuclear transcripts. This additional perimeter was omitted where cells were directly adjacent 
to each other. Any areas with poor nuclear segmentation were excluded manually from the analysis following 
examination of each segmented section. Single RNA transcripts for each target gene appeared as individual 
puncta and detection thresholds were adjusted manually until the mark-up accurately reflected the transcript 
distribution. Cells were defined as positive for expression of a given gene if they contained greater than four 
transcripts. Where eGFP distribution was analysed, this was performed manually using Neurolucida for Confo-
cal software (MBF Bioscience, Williston, VT, USA) as transcripts were less numerous than in the experiments 
described above. The entire z-stack was examined, and transcripts belonging to a cell were judged as those dis-
tributed either within the nucleus or immediately adjacent to it. Cells were categorised in such a way (using the 
hide marker feature) that positivity for eGFP and the other marker (i.e. Nmur2, Tac1, Tac2, Npr1) were allocated 
blindly to prior assessments.
Immunohistochemistry. Tissue for immunohistochemistry came from 9 GRP::eGFP mice (either sex, 
18–30 g) and 2 male GRP::eGFP;MrgDCreERT2;Ai9 mice (24, 29 g). The GRP::eGFP;MrgDCreERT2;Ai9 mice had 
received i.p. injections of 2 mg tamoxifen at least 10 days before perfusion fixation. The animals were deeply 
anaesthetised and perfused with fixative, containing 4% freshly depolymerised formaldehyde. Lumbar spinal 
cord segments were removed and stored in the same fixative for 2 h at 4 °C. In addition, we obtained fixed tissue 
from 2 GRP::eGFP;MrgA3::Cre;Ai14  mice19,20 and from 4 Tg-Avil (GENSAT)  mice35.
Multiple-labelling immunofluorescence reactions were performed as described  previously22,56 on 60 μm 
thick parasagittal or transverse sections cut from this tissue with a vibrating blade microtome (Leica VT1200 
or VT1000). The sources and concentrations of antibodies are listed in Table S3. Sections were incubated for 
3 days at 4 °C in primary antibodies diluted in PBS that contained 0.3 M NaCl, 0.3% Triton X-100 and 5% normal 
donkey serum, and then overnight in appropriate species-specific secondary antibodies (Jackson Immunore-
search, West Grove, PA, USA), which were raised in donkey and conjugated to Alexa488, Alexa647, Rhodamine 
Red, Pacific Blue or biotin. All secondary antibodies were diluted 1:500 (in the same diluent), apart from those 
conjugated to Rhodamine Red or Pacific Blue, which were diluted 1:100 and 1:200, respectively. Biotinylated 
secondary antibodies were revealed either with Pacific Blue conjugated to avidin (1:1,000; Life Technologies, 
Paisley, UK) or with a tyramide signal amplification (TSA) method (TSA kit tetramethylrhodamine NEL702001, 
Perkin Elmer Life Sciences, Boston, MA, USA). The TSA reaction was used to detect the VGLUT3 antibody. 
Following the immunoreaction, sections were mounted in anti-fade medium and stored at – 20 °C. They were 
scanned with a Zeiss LSM710 confocal microscope equipped with Argon multi-line, 405 nm diode, 561 nm solid 
state and 633 nm HeNe lasers. Confocal image stacks were obtained through a 63 × oil immersion lens (numerical 
aperture 1.4) with the confocal aperture set to 1 Airy unit or less. All analyses were performed with Neurolucida 
for Confocal software (MBF Bioscience, Williston, VT, USA).
Transverse sections from the Tg-Avil mice were reacted to reveal eGFP (guinea-pig antibody), PAP and 
SST, and confocal image stacks including the entire medio-lateral extent of the dorsal horn were acquired at a 
z-separation of 0.3 μm. Scans were initially viewed such that only the eGFP and SST channels were visible, and 
SST +/eGFP + boutons were sampled based on a grid system, as described  previously14. Between 94 and 159 (mean 
140) boutons per animal were selected and the presence or absence of PAP was then determined. For one of the 
animals, the locations of these boutons seen in a single section was plotted onto an outline of the dorsal horn.
Tissue from the GRP::eGFP;MrgA3::Cre;Ai14 and GRP::eGFP;MrgDCreERT2;Ai9 mice was cut into sagittal 
sections, which were reacted with antibodies against eGFP (guinea-pig antibody), Homer and mCherry.
Sections were initially viewed to allow identification of suitable GRP-eGFP cells, and 4 of these were selected 
from each animal, before the relationship to labelled primary afferents was visualised. As we have previously 
shown that GRP-eGFP cells were largely absent from the medial part of the dorsal horn (glabrous skin terri-
tory) in the L4-5  segments3, these areas were avoided when selecting cells to be traced. Confocal z-scans (0.2 μm 
separation) were obtained to include as much of the dendritic tree of each cell as could be identified within the 
section. The dendritic trees were reconstructed for as far as these could be followed in the confocal scans, and 
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the locations of Homer puncta in the dendritic spines and shafts were plotted onto these reconstructions. Only 
when this was completed was the channel corresponding to tdTomato revealed, and the presence or absence of a 
tdTomato profile adjacent to each Homer punctum was recorded. In this way, we determined the proportion of 
Homer puncta on each cell that were in contact with a labelled primary afferent bouton. Details of the numbers 
of Homer puncta and the lengths of reconstructed dendrites are given in Table S4. To determine the propor-
tion of synaptic output from each afferent type that was accounted for by GRP-eGFP cells, we used an unbiased 
grid sampling strategy to select Homer puncta that were associated with tdTomato+ boutons and subsequently 
determined whether these were in contact with an eGFP profile. In order to determine the proportion of excita-
tory synapses in the GRP-eGFP dendritic band that were associated with GRP-eGFP cells, we viewed only the 
Homer channel and sampled between 400 and 430 immunoreactive puncta per animal, before revealing the 
eGFP channel and noting whether these were within an eGFP profile.
To analyse input from other primary afferent classes, tissue from GRP::eGFP or GRP::eGFP;MrgA3::Cre;Ai14 
mice was cut into sagittal sections. These were immunoreacted to detect the following presynaptic bouton mark-
ers: (i) SST/PAP, (ii) CGRP, and (iii) VGLUT3. The combinations of antibodies used were as follows: (i) SST, 
PAP, Homer, GFP (guinea pig-antibody); (ii) CGRP, Homer, GFP (guinea pig-antibody); and (iii) VGLUT3, 
Homer, GFP (rabbit antibody). In order to investigate synaptic input from putative excitatory interneurons, we 
used antibody against VGLUT2 on sections from 5 different mice. In three of these cases, chicken anti-VGLUT2 
was added to combinations (ii) or (iii) above, while tissue from two further GRP::eGFP mice was reacted with 
guinea-pig anti-VGLUT2, together with rabbit anti-GFP and Homer antibody. Confocal scanning and cell recon-
struction were performed as described above. Once this was completed, the channel corresponding to the axonal 
marker in question was revealed and the presence or absence of an immunoreactive bouton adjacent to each 
Homer punctum recorded. Details of the numbers of Homer puncta and the lengths of reconstructed dendrites 
are given in Table S4. To determine the proportion of synaptic output from each afferent type that was associ-
ated with GRP-eGFP cells, we again used an unbiased grid sampling strategy to select Homer puncta that were 
associated with primary afferent boutons and subsequently determined whether these were in an eGFP profile.
Combined confocal and electron microscopy. To confirm that synapses were present at contacts 
between VGLUT3-immunoreactive boutons and dendrites of GRP-eGFP neurons, we used a combined con-
focal and electron microscopic  method37. Sagittal sections from lumbar spinal cord of two GRP::eGFP mice 
(either sex, 24–28 g) that had been fixed by perfusion with a solution containing glutaraldehyde (0.2%) and 
formaldehyde (4%) were processed for immunostaining with antibodies against eGFP (rabbit-antibody), Homer 
and VGLUT3. The immunoreaction was performed as described above, except that the sections were treated for 
30 min with 1% sodium borohydride (to minimise non-specific staining resulting from glutaraldehyde fixation) 
and antibodies were diluted in PBS that did not contain detergent. The secondary antibody mixture included 
fluorescent secondary antibodies to reveal eGFP, Homer and VGLUT3, together with a biotinylated antibody 
to reveal eGFP. Following this step, sections were incubated in avidin-HRP (Sigma-Aldrich, Gillinhgam, UK; 
E2886, 1:1,000) and mounted in anti-fade medium. One eGFP-immunoreactive cell was identified from each 
animal and scanned with the confocal microscope to reveal contacts from VGLUT3 containing boutons. The 
section containing the cell was then removed from the slide, reacted with diaminobenzidine to reveal the HRP-
labelled (GFP-immunoreactive) profiles, osmicated (1%  OsO4 for 20 min) and flat-embedded in Durcupan resin, 
as described  previously37. A series of ~ 100 ultrathin sections (silver interference colour, ~ 70 nm thickness) was 
cut through part of the cell with a diamond knife. The sections were collected in serial order on Formvar-coated 
slot grids, stained with uranyl acetate and lead citrate, and viewed with a Philips CM100 electron microscope 
(EM), equipped with a digital camera. The regions of dendrite that appeared in the ultrathin sections were iden-
tified based on their location in relation to landmarks (e.g. capillaries) that could be recognised in the confocal 
image stacks.
Data availability
The datasets generated and analysed during the current study are available from the corresponding authors on 
reasonable request.
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